2015
Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience
Ball MW, Sundi D, Reese AC, Meyer CF, Terezakis SA, Efron JE, Schoenberg MP, Epstein JI, Ahuja N, Bivalacqua TJ. Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience. Clinical Genitourinary Cancer 2015, 13: 435-440. PMID: 26003268, DOI: 10.1016/j.clgc.2015.04.011.Peer-Reviewed Original ResearchMeSH KeywordsChemoradiotherapy, AdjuvantDisease-Free SurvivalHumansMaleMiddle AgedNeoadjuvant TherapyProstatic NeoplasmsSurvival AnalysisConceptsCancer-specific survivalRecurrence-free survivalProstate sarcomaOverall survivalSurgical resectionLocal recurrenceMedian recurrence-free survivalFavorable cancer-specific survivalCommon presenting symptomRecords of patientsPatient demographic informationJohns Hopkins ExperienceActuarial OSConcurrent chemotherapyCurative intentMedian OSNeoadjuvant chemoradiationNeoadjuvant radiationOncological outcomesPresenting symptomMost patientsRFS ratesUrinary obstructionMetastatic recurrenceTumor characteristics
2013
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases
Karagkounis G, Torbenson MS, Daniel HD, Azad NS, Diaz LA, Donehower RC, Hirose K, Ahuja N, Pawlik TM, Choti MA. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer 2013, 119: 4137-4144. PMID: 24104864, PMCID: PMC3967132, DOI: 10.1002/cncr.28347.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesSurgical therapyBRAF mutationsLiver metastasesKRAS statusPrognostic impactKRAS mutationsMolecular biomarkersThird of patientsRecurrence-free survivalKRAS gene mutationsPrognostic determinantsColorectal metastasesSurgical cohortWorse survivalClinicopathologic factorsIndependent predictorsCancer surgeryClinicopathologic featuresTumor numberPrognostic significanceBRAF analysisColorectal cancerLiver surgeryLower incidence
2010
Disparity in limb-salvage surgery among sarcoma patients
Downing S, Ahuja N, Oyetunji TA, Chang D, Frederick WA. Disparity in limb-salvage surgery among sarcoma patients. The American Journal Of Surgery 2010, 199: 549-553. PMID: 20359572, DOI: 10.1016/j.amjsurg.2009.12.003.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAmputation, SurgicalAsianBlack or African AmericanFemaleHealth Services AccessibilityHealthcare DisparitiesHispanic or LatinoHumansLimb SalvageLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeoadjuvant TherapyOdds RatioProportional Hazards ModelsRadiotherapy, AdjuvantSarcomaSEER ProgramUnited StatesWhite PeopleConceptsLimb-sparing proceduresLimb salvage surgeryLimb salvagePreoperative radiationSarcoma patientsAfrican AmericansEnd Results (SEER) databaseAfrican American patientsSpecific surgical proceduresWhite patientsResults databaseTreatment modalitiesAmerican patientsSurgical proceduresPatientsMultivariate analysisBivariate analysisLogistic regressionSalvageSurgerySurvivalRecent studiesPrevious studiesTumorsAmericans
2008
Management of Extremity Soft Tissue Sarcomas
Hueman MT, Thornton K, Herman JM, Ahuja N. Management of Extremity Soft Tissue Sarcomas. Surgical Clinics Of North America 2008, 88: 539-557. PMID: 18514697, DOI: 10.1016/j.suc.2008.04.003.Peer-Reviewed Original ResearchMeSH KeywordsChemotherapy, AdjuvantCombined Modality TherapyHumansNeoadjuvant TherapyNeoplasm StagingPlastic Surgery ProceduresSarcoma